GE Power India Limited (NSE:GEPIL)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	22,723	16,777	17,839	6,669	10,252	19,247
Market Cap Growth	-5.95%	-5.95%	167.49%	-34.95%	-46.73%	-39.90%
Enterprise Value	18,628	15,284	20,711	8,922	15,740	20,490
Last Close Price	338.90	249.76	265.55	99.20	152.05	286.14
PE Ratio	11.19	8.26	-	-	-	27.32
PS Ratio	2.17	1.60	1.72	0.37	0.39	0.58
PB Ratio	7.18	5.30	25.93	2.87	1.52	1.98
P/TBV Ratio	7.18	5.30	25.96	2.87	1.52	1.98
P/FCF Ratio	7.23	5.34	9.91	7.67	23.01	-
P/OCF Ratio	7.11	5.25	9.78	7.43	20.87	-
EV/Sales Ratio	1.78	1.46	1.99	0.49	0.60	0.61
EV/EBITDA Ratio	-	-	-	-	-	16.52
EV/EBIT Ratio	-	-	-	-	-	20.70
EV/FCF Ratio	5.93	4.86	11.50	10.26	35.32	-
Debt / Equity Ratio	0.09	0.09	2.36	1.55	0.57	0.47
Debt / EBITDA Ratio	-	-	-	-	-	3.04
Debt / FCF Ratio	0.09	0.09	0.90	4.13	8.70	-
Asset Turnover	0.46	0.46	0.38	0.57	0.70	0.91
Inventory Turnover	8.14	8.14	9.46	16.88	15.08	11.90
Quick Ratio	1.01	1.01	0.84	0.92	1.05	1.04
Current Ratio	1.13	1.13	0.97	1.04	1.15	1.22
Return on Equity (ROE)	-30.85%	-30.85%	-90.68%	-97.01%	-35.06%	7.46%
Return on Assets (ROA)	-2.21%	-2.21%	-3.98%	-6.22%	-3.42%	1.68%
Return on Capital (ROIC)	-17.58%	-17.58%	-26.30%	-23.77%	-10.24%	4.99%
Return on Capital Employed (ROCE)	-	-	-	-	-	8.30%
Earnings Yield	8.93%	12.10%	-9.60%	-66.06%	-28.17%	3.66%
FCF Yield	13.83%	18.73%	10.10%	13.04%	4.35%	-24.99%
Dividend Yield	-	-	-	-	-	0.35%
Payout Ratio	-	-	-	-	-	19.09%
Total Shareholder Return	-	-	-	-	-	0.35%

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.